Aripiprazole Mylan Pharma (previously Aripiprazole Pharmathen) Europese Unie - Nederlands - EMA (European Medicines Agency)

aripiprazole mylan pharma (previously aripiprazole pharmathen)

mylan pharmaceuticals limited - aripiprazole - schizophrenia; bipolar disorder - psycholeptica - aripiprazole mylan pharma is geïndiceerd voor de behandeling van schizofrenie bij volwassenen en bij adolescenten van 15 jaar en ouder. aripiprazole mylan pharma is geïndiceerd voor de behandeling van matige tot ernstige manische episodes bij bipolaire i-stoornis en voor de preventie van een nieuwe manische episode bij volwassenen die ervaren voornamelijk manische episodes en wiens manische episodes gereageerd op aripiprazole behandeling. aripiprazole mylan pharma is geïndiceerd voor de behandeling van maximaal 12 weken van matige tot ernstige manische episodes bij bipolaire i-stoornis bij adolescenten in de leeftijd van 13 jaar en ouder.

Sorafenib Pharmascience 200 mg, filmomhulde tabletten Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

sorafenib pharmascience 200 mg, filmomhulde tabletten

pharmascience international ltd lampousas 1 1095 nicosia (cyprus) - sorafenibtosylaat 274 mg/stuk samenstelling overeenkomend met ; sorafenib 200 mg/stuk - filmomhulde tablet - cellulose, microkristallijn (e 460) ; croscarmellose natrium (e 468) ; hypromellose, type 2910 (3 - 15 mpa.s) (e 464) ; ijzeroxide rood (e 172) ; magnesiumstearaat (e 470b) ; natriumlaurilsulfaat (e 487) ; polyethyleenglycol (e 1521) ; titaandioxide (e 171)

Clopidogrel Taw Pharma (previously Clopidogrel Mylan) Europese Unie - Nederlands - EMA (European Medicines Agency)

clopidogrel taw pharma (previously clopidogrel mylan)

taw pharma (ireland) limited - clopidogrel hydrochloride - peripheral vascular diseases; stroke; myocardial infarction; acute coronary syndrome - antitrombotische middelen - , , , , secondary prevention of atherothrombotic events, , clopidogrel is indicated in: , - adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. , - adult patients suffering from acute coronary syndrome:,    - non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). ,     - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy. , , in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is), clopidogrel in combination with asa is indicated in:, - adult patients with moderate to high-risk tia (abcd2  score ≥4) or minor is (nihss  ≤3) within 24 hours of either the tia or is event.  , , prevention of atherothrombotic and thromboembolic events in atrial fibrillation, in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. , , for further information please refer to section 5. , , ,.

Lisinopril/Hydrochloorthiazide Double-e Pharma 20/12,5 mg, tabletten Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

lisinopril/hydrochloorthiazide double-e pharma 20/12,5 mg, tabletten

double-e pharma limited 17 corrig road 18 dublin (ierland) - hydrochloorthiazide ; lisinopril 2-water samenstelling overeenkomend met ; ; lisinopril - tablet - calciumwaterstoffosfaat 0-water (e 341) ; magnesiumstearaat (e 470b) ; mannitol (d-) (e 421) ; maÏszetmeel ; maÏszetmeel, gepregelatineerd, - lisinopril and diuretics

Stapressial 10 mg/5 mg/5 mg filmomhulde tabletten Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

stapressial 10 mg/5 mg/5 mg filmomhulde tabletten

les laboratoires servier - amlodipinebesilaat samenstelling overeenkomend met; amlodipine; atorvastatine calcium 3-water samenstelling overeenkomend met; atorvastatine; perindopril arginine samenstelling overeenkomend met; perindopril; - filmomhulde tablet - atorvastatin, amlodipine and perindopril

Stapressial 20 mg/10 mg/10 mg filmomhulde tabletten Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

stapressial 20 mg/10 mg/10 mg filmomhulde tabletten

les laboratoires servier - amlodipinebesilaat samenstelling overeenkomend met; amlodipine; atorvastatine calcium 3-water samenstelling overeenkomend met; atorvastatine; perindopril arginine samenstelling overeenkomend met; perindopril; - filmomhulde tablet - atorvastatin, amlodipine and perindopril

Stapressial 20 mg/10 mg/5 mg filmomhulde tabletten Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

stapressial 20 mg/10 mg/5 mg filmomhulde tabletten

les laboratoires servier - amlodipinebesilaat samenstelling overeenkomend met; amlodipine; atorvastatine calcium 3-water samenstelling overeenkomend met; atorvastatine; perindopril arginine samenstelling overeenkomend met; perindopril; - filmomhulde tablet - atorvastatin, amlodipine and perindopril

Stapressial 20 mg/5 mg/5 mg filmomhulde tabletten Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

stapressial 20 mg/5 mg/5 mg filmomhulde tabletten

les laboratoires servier - amlodipinebesilaat samenstelling overeenkomend met; amlodipine; atorvastatine calcium 3-water samenstelling overeenkomend met; atorvastatine; perindopril arginine samenstelling overeenkomend met; perindopril; - filmomhulde tablet - atorvastatin, amlodipine and perindopril